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Summary
 
Insulin-dependent diabetes mellitus (IDDM) is assumed to be a T cell–mediated autoimmune
 
disease. To investigate the role of Fas-mediated cytotoxicity in pancreatic 
 
b
 
 cell destruction,
we established nonobese diabetic (NOD)-lymphoproliferation (
 
lpr
 
)/
 
lpr
 
 mice lacking Fas. Out
of three genotypes, female NOD-
 
1
 
/
 
1
 
 and NOD-
 
1
 
/
 
lpr
 
 developed spontaneous diabetes by
the age of 10 mo with the incidence of 68 and 62%, respectively. In contrast, NOD-
 
lpr
 
/
 
lpr
 
 did
not develop diabetes or insulitis. To further explore the role of Fas, adoptive transfer experi-
ments were performed. When splenocytes were transferred from diabetic NOD, male NOD-
 
1
 
/
 
1
 
 and NOD-
 
1
 
/
 
lpr
 
 developed diabetes with the incidence of 89 and 83%, respectively,
whereas NOD-
 
lpr
 
/
 
lpr
 
 did not show glycosuria by 12 wk after transfer. Severe mononuclear cell
infiltration was revealed in islets of NOD-
 
1
 
/
 
1
 
 and NOD-
 
1
 
/
 
lpr
 
, whereas islet morphology
remained intact in NOD-
 
lpr
 
/
 
lpr.
 
 These results suggest that Fas-mediated cytotoxicity is re-
quired to initiate 
 
b
 
 cell autoimmunity in NOD mice. Fas–Fas ligand system might be critical
for autoimmune 
 
b
 
 cell destruction leading to IDDM.
 
A
 
ccumulating evidence has elucidated that insulin-depen-
dent diabetes mellitus (IDDM) is a T cell–mediated au-
toimmune disease (1, 2). Histological examination of the
IDDM pancreas revealed that mononuclear cells infiltrated
into the islet (insulitis) and the infiltrate was mainly com-
posed of T cells (3–5). The nonobese diabetic (NOD)
mouse is an excellent animal model of human IDDM, and
possesses a similar T cell predominance in the islet infiltrate
(6). The significant role of T cells in IDDM has been ex-
tensively studied by using this mouse model. T cell manip-
ulation by an administration of mAb decreased the inci-
dence of diabetes and insulitis (7, 8). Insulitis and diabetes
were adoptively transferred into neonatal or irradiated
young NOD by splenic T cells, T cell lines, and T cell
clones from diabetic NOD (9–12). Possible roles of these
cells are to give an initial damage to 
 
b
 
 cells for launching
inflammatory process, and/or to secrete cytokines for re-
cruiting and activating other T cells, and/or to put the final
 
damage to 
 
b
 
 cells for causing diabetes. Thus, T cells are es-
sentially involved in the pathogenesis of IDDM, yet exact
mechanisms of pancreatic 
 
b
 
 cell destruction remain ob-
scure.
Recent studies have exposed that T cell–mediated cyto-
toxicity comprised two major pathways, perforin- and Fas-
based mechanisms (13–15). Perforin is a protein present in
the cytoplasmic granules of CTLs and secreted to form
pores on target cell membranes. The presence of perforin
in CD8
 
1
 
 T cells in insulitis lesions of NOD mice suggested
 
b
 
 cell lysis by a perforin-based mechanism (16). However,
one study using transgenic mice expressing glycoprotein of
lymphocytic choriomeningitis virus (LCMV) in 
 
b
 
 cells,
transfer of perforin-deficient glycoprotein of LCMV–spe-
cific T cells failed to prevent insulitis (17). That study indi-
cates that the perforin-independent pathway is required to
initiate autoimmunity against pancreatic 
 
b
 
 cells.
Fas-dependent cytotoxicity is a possible molecular mech-
anism for triggering 
 
b
 
 cell destruction. To address this is-
sue, we established Fas-lacking NOD mice by introducing
lymphoproliferation (
 
lpr
 
) mutation from MRL-
 
lpr
 
/
 
lpr
 
. The
MRL-
 
lpr
 
/
 
lpr
 
 mouse carries an insertion of an early trans-
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posable element in intron 2 of the 
 
Fas
 
 gene leading to pre-
mature termination of the transcript and defective Fas ex-
pression on cell surface (18). Generated NOD-
 
lpr
 
/
 
lpr
 
 did
not develop diabetes or insulitis. In addition, splenocyte-
transfer did not provoke insulitis or diabetes either. These
results suggest that Fas-mediated cytotoxicity is critical to
initiate 
 
b
 
 cell autoimmunity in NOD mice. Fas–Fas ligand
(FasL) system might be required in an initial step of au-
toimmune 
 
b
 
 cell destruction leading to IDDM.
 
Materials and Methods
 
Mice.
 
NOD/shi/osa mice were originated from the colony at
Center for Experimental Animals Development (Shionogi, Koka,
Japan) and bred under specific pathogen-free conditions at the In-
stitute of Animal Research (Osaka University Medical School,
Osaka, Japan). They were monitored for the development of dia-
betes with Tes-Tape (Eli Lilly, Indianapolis, IN) weekly. The in-
cidence of spontaneous diabetes in our colony was 77% in females
and 40% in males by 32 wk of age. MRL-
 
lpr
 
/
 
lpr
 
 mice were pur-
chased from Japan SLC (Hamamatsu, Japan). Experiments were
approved by Osaka University Medical School Animal Care and
Use Committee and performed according to Osaka University
Medical School Guideline for the Care and Use of Laboratory
Animals.
 
Breeding of NOD-lpr/lpr Mice.
 
MRL-
 
lpr
 
/
 
lpr
 
 mice (H-2
 
k
 
; K
 
k
 
,
I-A
 
k
 
, I-E
 
1
 
, D
 
k
 
) were outcrossed to NOD mice (H-2
 
g7
 
; K
 
d
 
, I-A
 
g7
 
,
I-E
 
2
 
, D
 
b
 
), and F
 
1
 
 were backcrossed in NOD background. At the
N
 
2
 
 generation, H-2 was typed to select breeders homozygous for
H-2
 
g7
 
 since this characteristic MHC haplotype was essential for
insulitis and diabetes (19). Cervical lymphnode was biopsied and
dispersed cells (10
 
6
 
) were stained with the following monoclonal
antibodies. SF1-1.1 for K
 
d
 
 and 28-8-6S for D
 
b
 
 were purchased
from PharMingen (San Diego, CA) and 14-4-4S for I-E from
Cedarlane (Hornby, Ontario, Canada). 11-4.1 for K
 
k
 
, H116-
32.R7 for I-A
 
k
 
, and 10-2.16 for I-A
 
g7
 
 were provided by Dr. M.
Hattori (Harvard Medical School, Boston, MA). FITC-conju-
gated anti–mouse IgG Fc (Cappel, Durham, NC) was used as a
secondary antibody. Flow cytometric analysis was performed on a
FACScan
 
Ò
 
 (Becton Dickinson, Mountain View, CA). 
 
lpr
 
 mutation
was also screened at each step of backcrossing. Tail was biopsied
and extracted DNA was subjected to PCR with two different
pairs of primers constructed according to the published sequence
(20). The first pair is composed of NIL-1, 5
 
9
 
-CAG CAG GAA
TCC TAT GAG GT-3
 
9
 
 and NIL-2, 5
 
9
 
-CTC GCA ACG TGA
ACG GTT CG-3
 
9
 
, yielding a band of 381 bp for the mutated al-
lele. The second pair is composed of NIL-3, 5
 
9
 
-CCT TCA TAA
CTG GTG TCG CA-3
 
9
 
, and NIL-4, 5
 
9
 
-GCA GAG ATG CTA
AGC AGC AG-3
 
9
 
, yielding a band of 346 bp for the mutated al-
lele.
 
Genotyping and Phenotyping of Fas Allele.
 
At the N
 
6
 
 genera-
tion, heterozygotes for 
 
lpr
 
 were intercrossed and N
 
6
 
F
 
1
 
 was ob-
tained. Genotype of the 
 
Fas
 
 allele was determined by PCR with
Takara Ex Taq (Takara Shuzo, Otsu, Japan) and one set of prim-
ers, NIL-1, and NIL-4 covering an early transposable element. 
 
lpr
 
type yielded a band of 5.7 kbp and wild type yielded a band of
265 bp. Phenotype was confirmed by flow cytometry and North-
ern blot analysis. Thymocytes and splenocytes were dispersed into
single cells (10
 
6
 
) and stained with Jo2 anti–mouse Fas antibody
(PharMingen) followed by FITC-conjugated anti–hamster IgG
(PharMingen), or a combination of PE-conjugated anti-CD4
(GK1.5;  Becton Dickinson) and FITC-conjugated anti-CD8 (YTS
 
169.4; Cedarlane), or a combination of PE-conjugated anti-B220
(RA3-6B2; GIBCO BRL, Gaitherburg, MD) and FITC-conju-
gated anti-CD3 (145-2C11; PharMingen). Dead cells were ex-
cluded by 1 
 
m
 
g/ml of propidium-iodine (Sigma Chemical Co., St.
Louis, MO) staining. For Northern blotting, total RNA was pre-
pared from tissue using TRIzol (GIBCO BRL) and blotted onto
a nylon membrane. EcoRI fragment of mouse cDNA was labeled
with 
 
32
 
P and used for hybridization as described (21).
Monitoring Spontaneous Development of Diabetes. After geno-
typing, female congenic mice were monitored for the develop-
ment of diabetes with Tes-Tape weekly. Diabetes was diagnosed
when Tes-Tape indicated .21 and hyperglycemia .300 mg/dl
was confirmed by the measurement of blood glucose using Glu-
test E (Sanwa Kagaku Kenkyusho, Nagoya, Japan).
Adoptive Cell Transfer. Cell transfer was performed according
to the method of Wicker et al. (22) with slight modification.
Splenocytes from diabetic NOD were isolated in RPMI 1640
medium supplemented with 10% fetal bovine serum. RBCs were
excluded by a lysis with NH4Cl. After washing, numeration, and
viability evaluation, splenocytes (5 3 107) were intravenously in-
jected into sublethally irradiated male recipients. The dose of irra-
diation was 800 rad, and the age of recipients was between 9 and
13 wk when none of NOD males spontaneously developed dia-
betes. Development of diabetes was monitored three times a week
by Tes-Tape after transfer.
Histological Examination. Pancreas was fixed on a filter paper
in neutral-buffered formalin, and paraffin-embedded sections were
prepared as maximum plane could be observed. Two nonconsec-
utive hematoxylin and eosin sections were examined. For trans-
ferred mice, sections were scored for insulitis, and the number of
islets was counted by one investigator in a blind fashion. Score of
insulitis was 0, normal; 1, peri-insulitis; 2, mononuclear cell infil-
tration in ,50% of the area of the islet; 3, mononuclear cell infil-
tration in 50% or more of the area of the islet.
Analysis of Microsatellite Markers. To examine the extent of
bringing in MRL genes surrounding lpr mutation to the NOD
genetic background, genomes of the N6 backcross used for the
intercross were assessed with locus-specific microsatellite markers.
IDDM susceptibility (Idd) genes with significant evidence of link-
age to insulitis and diabetes (23, 24) were assessed similarly. Mi-
crosatellite markers were selected from the published data (25)
and the database released by the Whitehead Institute/Massachu-
setts Institute of Technology Center for Genome Research (Cam-
bridge, MA), and screened for polymorphisms between NOD
and MRL strains. After MapPairsTM (Res. Genetics, Huntsville,
AL) were subsequently used in this study: Idd3, D3Mit270; Idd5,
D1Mit122, and D1Mit318; Idd10, D3Mit10, and D3Mit140;
chromosome 19, D19Mit11, D19Mit34, D19Mit43, D19Mit54,
and D19Mit69.
Statistical Analysis. The Kaplan-Meier method was used for
the calculation of diabetes incidence. Insulitis scores and the
number of islet were compared using the Kruskal-Wallis test.
Results
Genotyping and Phenotyping. Genotyping at the Fas lo-
cus determined NOD-1/1, NOD-1/lpr, and NOD-lpr/
lpr. They were all maturated, but NOD-lpr/lpr showed
marked lymphadenopathy at z4 mo of age. This is due to
impaired transcription of the Fas gene, defective expression
of Fas antigen, and consequent accumulation of CD42CD82
CD3lowB2201 lymphocytes (Fig. 1). Although the pheno-615 Itoh et al. Brief Definitive Report
type of NOD-lpr/lpr closely resembled a parental strain,
MRL-lpr/lpr, NOD-lpr/lpr did not show high mortality as
MRL-lpr/lpr making it possible to observe them until 10 mo
of age. NOD-1/1 and NOD-1/lpr could hardly be dis-
criminated by the phenotype.
Spontaneous Development of Diabetes. Female NOD-1/1
and NOD-1/lpr developed spontaneous diabetes after 3
mo of age. The incidence increased with age and reached
68% in NOD-1/1 and 62% in NOD-1/lpr by 10 mo of
age (Fig. 2). This time course is comparable with that in
NOD mice in our colony. In contrast, none of NOD-lpr/lpr
developed diabetes during this observation period. 
Diabetes after Adoptive Cell Transfer. Prevention of sponta-
neous diabetes might be due to the distorted cell propor-
tion of immune cells since unusual CD42CD82 T cells ac-
cumulated in NOD-lpr/lpr. To avoid this influence, we
performed transfer experiments from diabetic NOD to
sublethally irradiated young congenic mice. In a total of
four experiments, 8 of 9 NOD-1/1 (89%) and 10 of 12
NOD-1/lpr (83%) developed diabetes, whereas 0 of 7
NOD-lpr/lpr (0%) became diabetic during 12 wk of obser-
vation period (Fig. 3).
Histological Examination. Mild to severe insulitis existed
in the pancreas of both genders of NOD-1/1 and NOD-
1/lpr, irrespective of the development of diabetes (Fig. 4).
In contrast, mononuclear cells were barely found in and
around the islet of both genders of NOD-lpr/lpr. The se-
verity of insulitis and the number of islets were evaluated in
transferred mice. The average scores of insulitis (mean 6
SE) were 2.47 6 0.15, 2.36 6 0.19, and 0.02 6 0.02 in Figure 1. Fas mRNA expression in the thymus (A), Fas expression on
thymocytes (B), and two-color flow cytometric analysis of cell surface
markers on splenocytes (C) of NOD-1/1 and NOD-lpr/lpr.
Figure 2. Cumulative inci-
dence of spontaneous diabetes in
female NOD-1/1 ( n  5  19),
NOD-1/lpr ( n  5  18), and
NOD-lpr/lpr (n 5 17).
Figure 3. Cumulative inci-
dence of adoptively transferred
diabetes in male NOD-1/1
(n  5 9), NOD-1/lpr ( n  5  12),
and NOD-lpr/lpr (n 5 7).
Figure 4. Hematoxylin and eosin staining of pancreatic islets of NOD-
1/1 (A) and NOD-lpr/lpr (B) transferred with splenocytes from diabetic
NOD. Original magnification was 200.616 Fas Requirement for Autoimmune Diabetes in Mice
NOD-1/1, NOD-1/lpr, and NOD-lpr/lpr, respectively
(P ,0.01). The number of islets per section was decreased
in NOD-1/1 (9.89 6 2.78), and NOD-1/lpr (12.3 6
2.39), compared with that in NOD-lpr/lpr (52.1 6 10.2)
(P ,0.01). Most islets of NOD-1/1 and NOD-1/lpr
were inflamed and small in size, indicating the decrease in
number resulted from destruction of the islet. Conversely,
islets of NOD-lpr/lpr remained normal in morphology.
Analysis of Microsatellite Markers. Genetic regions encom-
passing  lpr mutation were assessed in three pairs of the N6
littermates used for producing the intercross. Although the
position of recombination between NOD and MRL strains
varied among the pairs (Table 1), either the incidence of
diabetes in NOD-1/1 and NOD-1/lpr or the protection
of insulitis and diabetes in NOD-lpr/lpr did not change
among the F1 intercross of these pairs. Markers linked to
Idd3, Idd5, and Idd10 loci were all homozygous for NOD
alleles.
Discussion
The dominant role of T cells in the pathogenesis of
IDDM has been strongly suggested by many investigators,
but exact molecular mechanisms have remained elusive.
Recent advances in the understanding of T cell–mediated
cytotoxicity disclosed the possibility that b cells were de-
stroyed by perforin- or Fas-based mechanisms. In fact, per-
forin-deficient LCMV-transgenic mice did not develop
diabetes when infected with LCMV, suggesting that per-
forin-dependent cytotoxicity was crucial to cause diabetes
by eliminating b cells (17). However, they did show insuli-
tis, indicating that triggering islet inflammation required
the perforin-independent pathway, which initially im-
paired  b cells, exposed autoantigens to antigen-presenting
cells, and launched an autoimmune cascade to diabetes.
Our observation revealed that the Fas-dependent pathway
might be precisely a complementary mechanism to initiate
b cell destruction. NOD mice became completely free of
insulitis by obtaining Fas-disrupting spontaneous mutation
of lpr. Of course, there is a possibility that the lack of insu-
litis in NOD-lpr/lpr is due to the distorted T cell composi-
tion that contained unusual CD42CD82 cells. To avoid
this influence, we performed transfer experiments from di-
abetic NOD to sublethally irradiated young congenic mice.
Even in this protocol, insulitis and diabetes were com-
pletely prevented in NOD-lpr/lpr, whereas they were rap-
idly induced in the littermates not homozygous for lpr. This
finding strongly suggests that autoimmune cascade against
pancreatic b cells is blocked at an early stage in Fas-lacking
NOD mice. Transferred autoreactive T cells might initially
damage b cells through Fas–FasL system, and then substan-
tially destroy fragile target cells by other mediators such as
perforin and cytokines. Two groups have reported that b
cells can express Fas when stimulated with IL-1 (26, 27).
IL-1 is a cytokine secreted by macrophages, the participa-
tion of which has already been proved essential for the on-
set of diabetes as well as T cells (28).
During the process of backcrossing, we screened H-2g7
(Idd1) homozygotes at the N2 generation and lpr mutation
at each generation. This implies that the prevention of in-
sulitis and diabetes observed in NOD-lpr/lpr might be due
to the absence of other Idd genes or the presence of un-
known recessive genes linked to lpr mutation. However, mi-
crosatellite marker analysis revealed that other Idd loci sig-
nificantly linked to insulitis and diabetes were replaced by
the NOD alleles. In addition, either the incidence of diabe-
tes in NOD-1/1 and NOD-1/lpr, or the protection of
insulitis and diabetes in NOD-lpr/lpr did not change
among the intercross with various recombinational posi-
tions from the Fas locus. This suggests that lpr mutation it-
self is responsible for the lack of disease in NOD-lpr/lpr.
To elaborate effective intervention therapies for IDDM,
a better understanding of the pathogenesis is required.
Given the fact that the Fas–FasL system is involved in the
development of autoimmune diabetes, interference of this
molecular mechanism would be a potent therapeutic strategy.
Soluble form of Fas and anti-FasL Ab suppressed Fas-mediated
cytotoxic activity (29, 30). Inhibitors of IL-1b–converting
enzyme– or CPP32–like proteases blocked Fas-induced
death signaling (31). If we devise a system to deliver one of
these molecules at the site of inflammation, it might be a
new beneficial treatment without systemic harmful effects
for pre- and early stage of IDDM.
In conclusion, we have shown that autoimmune b cell
Table 1. Analysis of Microsatellite Markers of the N6 NOD-1/lpr Mice Used for the Intercross
Pair
No.
ID
D19Mit43
(0 cM)
D19Mit69
(9 cM)
Fas
(24 cM)
D19Mit11
(28 cM)
D19Mit54
(39 cM)
D19Mit34
(45 cM) Female Male
1 No. 272 D/D D/D 1/lpr D/M D/M D/M
No. 277 D/D D/D 1/lpr D/M D/D D/D
2 No. 278 No. 283 D/D D/D 1/lpr D/M D/M D/M
3 No. 284 No. 286 D/D D/D 1/lpr D/D D/D D/D
D/D, NOD homozygote at the indicated locus; D/M, NOD/MRL heterozygote at the indicated locus; 1/lpr, NOD/MRL heterozygote at the Fas
locus.617 Itoh et al. Brief Definitive Report
destruction is prevented by introduction of Fas-disrupting
lpr mutation into NOD mice. Considering that islet in-
flammation was nearly completely abrogated, Fas-based cy-
totoxic mechanism is assumed to be critical in an initial step
of b cell autoimmunity. Since there have been many b
cell–specific T cell clones and lines, the analysis of cyto-
toxic pathways and abilities to induce diabetes of these cells
would provide further evidence concerning the Fas–FasL
system in IDDM.
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